And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 ...

"Ozempic 2.0" has been floating around online, as a trending nickname for the next generation of weight loss drugs that are in the works.

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients. “ Ozempic is about to be ...

The Food and Drug Administration is set to treat the application under its priority program to accelerate the review of ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Novo Nordisk reported promising mid-stage results for its experimental obesity drug amycretin in diabetes patients on Tuesday ...

The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...

Shares of Novo Nordisk ($NVO), maker of the popular obesity drug Wegovy, rose over 2% early Tuesday on the weight loss ...